Medicare Enrolled
Dr. Vaibhav Verma, MD
Hematology & Oncology · Canfield, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Verma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Verma?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Verma
Dr. Vaibhav Verma is a hematology & oncology specialist in Canfield, OH, with 16 years of NPI registration. Based on federal Medicare data, Dr. Verma performed 2,286 Medicare services across 970 unique beneficiaries.
Between the years covered by Open Payments, Dr. Verma received a total of $11,244 from 83 pharmaceutical and/or device companies across 535 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Verma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 21% volume in OH
$11,244 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,286
Medicare services
Top 21% in OH for hematology & oncology
970
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~143 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
366 | $8 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
357 | $8 | $33 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
320 | $62 | $105 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
218 | $61 | $110 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
214 | $10 | $50 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
138 | $100 | $225 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
119 | $11 | $65 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
89 | $13 | $45 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
89 | $92 | $175 |
| Iron level test | 88 | $6 | $48 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
88 | $12 | $35 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
60 | $94 | $275 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $118 | $250 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
30 | $18 | $55 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
30 | $4 | $15 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
24 | $15 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.6% high complexity
5.2% medium
92.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,244
Total received (2018-2024)
Avg $1,606/year across 7 years
Top 26% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
535
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,904 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$341 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,463
2023
$3,098
2022
$2,671
2021
$1,452
2020
$37
2019
$214
2018
$309
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$221
Novartis Pharmaceuticals Corporation
$209
PFIZER INC.
$203
AstraZeneca Pharmaceuticals LP
$193
Lilly USA, LLC
$173
Blueprint Medicines Corporation
$172
Merck Sharp & Dohme LLC
$155
Takeda Pharmaceuticals U.S.A., Inc.
$151
GlaxoSmithKline, LLC.
$132
Celgene Corporation
$131
Astellas Pharma US Inc
$128
ABBVIE INC.
$110
Janssen Biotech, Inc.
$110
E.R. Squibb & Sons, L.L.C.
$80
Amgen Inc.
$76
Genmab U.S., Inc.
$70
Gilead Sciences, Inc.
$70
Genentech USA, Inc.
$67
SOBI, INC
$58
Novo Nordisk Inc
$57
Acrotech Biopharma Inc.
$56
Pharmacosmos Therapeutics Inc.
$54
GENZYME CORPORATION
$52
Daiichi Sankyo Inc.
$52
TAIHO ONCOLOGY, INC.
$51
Incyte Corporation
$48
Tempus AI, Inc
$46
EMD Serono, Inc.
$43
SERVIER PHARMACEUTICALS LLC
$43
JAZZ PHARMACEUTICALS INC.
$41
Agios Pharmaceuticals, Inc.
$41
Kyowa Kirin, Inc.
$31
Alexion Pharmaceuticals, Inc.
$25
Tolmar, Inc.
$25
Biocon Biologics Inc
$24
Regeneron Healthcare Solutions, Inc.
$23
Octapharma USA, Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$22
ARRAY BIOPHARMA INC
$22
Dendreon Pharmaceuticals LLC
$21
ADC Therapeutics America, Inc.
$20
Spectrum Pharmaceuticals Inc.
$18
Ipsen Biopharmaceuticals, Inc
$16
Karyopharm Therapeutics Inc.
$16
Apellis Pharmaceuticals, Inc.
$16
Azurity Pharmaceuticals, Inc.
$15
Emmaus Medical, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Rigel Pharmaceuticals, Inc.
$11
Top 3 companies account for 18.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$737
AstraZeneca Pharmaceuticals LP
$570
PFIZER INC.
$561
E.R. Squibb & Sons, L.L.C.
$523
Merck Sharp & Dohme LLC
$518
Janssen Biotech, Inc.
$479
Takeda Pharmaceuticals U.S.A., Inc.
$469
Celgene Corporation
$460
Amgen Inc.
$451
GlaxoSmithKline, LLC.
$357
Eisai Inc.
$353
Lilly USA, LLC
$343
Astellas Pharma US Inc
$343
Genentech USA, Inc.
$326
GENZYME CORPORATION
$311
Regeneron Healthcare Solutions, Inc.
$281
Blueprint Medicines Corporation
$273
Pharmacyclics LLC, An AbbVie Company
$185
ABBVIE INC.
$158
Incyte Corporation
$153
Pharmacyclics LLC, an AbbVie Company
$153
EMD Serono, Inc.
$145
AVEO Pharmaceuticals, Inc.
$143
ImmunoGen, Inc.
$130
Genmab U.S., Inc.
$109
Dendreon Pharmaceuticals LLC
$108
Gilead Sciences, Inc.
$103
Seagen Inc.
$97
Daiichi Sankyo Inc.
$93
Bayer HealthCare Pharmaceuticals Inc.
$88
Alexion Pharmaceuticals, Inc.
$85
Ipsen Biopharmaceuticals, Inc
$84
Octapharma USA, Inc.
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
EISAI INC.
$77
Pharmacosmos Therapeutics Inc.
$75
SOBI, INC
$72
ADC Therapeutics America, Inc.
$72
Karyopharm Therapeutics Inc.
$69
Rigel Pharmaceuticals, Inc.
$67
JAZZ PHARMACEUTICALS INC.
$65
TAIHO ONCOLOGY, INC.
$65
AbbVie Inc.
$59
Novo Nordisk Inc
$57
Acrotech Biopharma Inc.
$56
Stemline Therapeutics Inc.
$51
Tempus AI, Inc
$46
Biocon Biologics Inc
$46
Myriad Genetic Laboratories, Inc.
$44
SERVIER PHARMACEUTICALS LLC
$43
Kite Pharma, Inc.
$42
Acrotech Biopharma LLC
$41
Agios Pharmaceuticals, Inc.
$41
PUMA BIOTECHNOLOGY, INC.
$39
ARRAY BIOPHARMA INC
$39
BeiGene USA, Inc.
$39
Jazz Pharmaceuticals Inc.
$38
Exelixis Inc.
$37
G1 Therapeutics, Inc.
$37
CTI BioPharma Corp.
$34
MorphoSys, US Inc.
$33
TerSera Therapeutics LLC
$33
Merck Sharp & Dohme Corporation
$33
Sobi, Inc
$32
Emmaus Medical, Inc.
$32
Spectrum Pharmaceuticals Inc.
$32
Epizyme, Inc.,
$32
Kyowa Kirin, Inc.
$31
Global Blood Therapeutics, Inc.
$27
Myovant Sciences Inc.
$26
Tolmar, Inc.
$25
Acceleron Pharma, Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$22
Mirati Therapeutics, Inc.
$21
Mylan Institutional Inc.
$20
Puma Biotechnology, Inc.
$20
EUSA Pharma (US) LLC
$19
Adaptive Biotechnologies Corporation
$18
Apellis Pharmaceuticals, Inc.
$16
Azurity Pharmaceuticals, Inc.
$15
Aveo Pharmaceuticals, Inc.
$13
Taiho Oncology, Inc.
$12
Dova Pharmaceuticals
$11
Top 3 companies account for 16.6% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALPROLIX · ALUNBRIG · AREXVY · AYVAKIT · Abraxane · Alecensa · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Columvi · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · ERLEADA · EVENITY · EXKIVITY · Elahere · Empaveli · Endari · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · FULPHILA · Fabhalta · GAZYVA · GILOTRIF · HYQVIA · Halaven · Hulio · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PRECISETUMOR · PROMACTA · PROVENGE · PYRUKYND · Padcev · Phesgo · Pomalyst · Poteligeo · REBLOZYL · ROLVEDON · RYBREVANT · Reblozyl · Rezlidhia · SARCLISA · SCEMBLIX · SYLVANT · Stivarga · Sylvant · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Tivdak · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · Vanflyta · Venclexta · Vonjo · XALKORI · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZIIHERA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
19
Per 100K population
8.4
County median income
$55,576
Nearest hospital
HMHP ST ELIZABETH BOARDMAN HEALTH CENTER
5.5 mi
5.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Verma is a clinical cardiology specialist, with above-average Medicare volume (top 21% in OH), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Verma experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Verma performed 366 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Verma receive payments from pharmaceutical companies?
Yes. Dr. Verma received a total of $11,244 from 83 companies across 535 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Verma's costs compare to other hematology & oncology specialists in Canfield?
Dr. Verma's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Verma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Canfield
Browse hematology & oncology specialists in Canfield ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology